HARBIN, China, July 13 /PRNewswire-Asia/ -- China Kangtai Cactus Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that the company plans to begin marketing cactus hog feed in the forth quarter in 2009, following the successful launch of cactus cattle feed and fish feed in July 2008. The new patented hog feed is expected to increase 2009 sales by approximately $330,000.
China Kangtai CEO Jinjiang Wang said, "China is the world's largest hog producing country having slaughtered 625 million hogs in 2008, compared to approximately 100 million hogs in the U.S. China also has the world's largest consumer base for pork consumption. Over 65% of all meat consumed in China is pork. The cactus hog feed market shows huge growth potential. Hog producers are constantly seeking ways to improve the health and productivity of their livestock. Our cactus products are proven to enhance pork production."
Based on scientific studies of animal nutrition and immunology,
cactus-derived hog feed provides nutrition, boosts immune systems and prevents sepsis and inflammatory illnesses. Studies have shown that Kangtai's cactus feed substantially increases productivity, quality and health of hog herds thereby improving the quality of pork.
China Kangtai was awarded patents from China's State Intellectual Property Office in 2008. The patent numbers for the company's cactus hog feed and hog feed additive are 2004100437683 and 2004100438046 respectively.
About China Kangtai Cactus Biotech, Inc.
China Kangtai Cactus Biotech Inc. is a leading grower, developer, producer and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 provinces and 2 municipalities. More information may be found at http://www.biocactus.com or e-mail: chinakangtai@gmail.com.
An investment profile on China Kangtai Cactus Biotech Inc. is available at http://www.hawkassociates.com/profile/ckgt.cfm . For an online investor relations kit, visit http://www.hawkassociates.com . For more investor-related questions, contact Susan Zhou, Hawk Associates, at 305-451-1888, e-mail: cactus@hawkassociates.com. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/ .
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
Susan Zhou
Hawk Associates
Tel: +1-305-451-1888
Email: cactus@hawkassociates.com
